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Abstract 
The lung carcinoma occurs when the cells of healthy lung tissue begin with uncontrolled structural proliferation and 
form a tumor formation in the lungs. For the purposes of this paper was used data from the Center for Public Health – 
Strumica, Republic of Northern Macedonia in the period of 2013 to 2017 ie within 5 years. The results show that in 
Strumica, for a period of five years, the total number of people diagnosed with lung cancer is 265. According the results 
in 2014 and 2015 the number of diagnosed patients is increasing and in 2016 and 2017 the number of patients is 
declining. 80% are male patients and 20% female. The most diagnosed patients with lung cancer in Strumica are on age 
from 59 to 65. The youngest patient with lung cancer is at the age of 24 and the oldest is at the age of 89. From the 
analysis of the Institute of Public Health, the highest rate of lung cancer mortality is in 2016 ie 43.5 % and the lowest 
mortality rate has in 2015 with 40.6%. In the Republic of Macedonia the number of patients with lung cancer is 
increasing. At the last few years the number of new cases per year is over 900 patients. Globally, lung cancer is a very 
common phenomenon that continues to increase.  
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1. Introduction
The classification of lung carcinomas is according to the size and appearance of malignant cells, under a microscope. 
Therefore they are classified into two general classes: non-small cell and small cell lung cancer. The spectrum of 
carcinogenic agents that can lead to the induction of cellular changes and malignant transformation is very wide. Lung 
cancer accounts for 12–16% of the total percentage of malignant diseases. 
Smoking is number one and the most important risk factor, while nonsmokers account for 15% of lung cancer cases, 
the disease is often attributed to a combination of genetic factors, asbestos exposure, radon, air pollution, diet and 
passive smoking. Lung carcinomas are the second leading cause of death in the male population and the third leading 
cause of death in the female population according to World Health Organization data. 
Non-small cell carcinoma is the most common and accounts for 75% of all lung cancers. There are three main types of 
non-small cell carcinoma: adenocarcinoma, squamous cell carcinoma, and large-cell anaplastic lung cancer. Five-year 
survival in all patients is 10-13%, in patients treated exclusively surgically it is 55-65%. Non-small cell lung carcinoma 
has a worse prognosis because it metastasizes early. This cancer grows rapidly and spreads early in the course of the 
disease, 60-70% have metastatic disease at the moment of detection. Two-year survival is 20% and five-year survival 
is less than 5%. 
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Signs and symptoms in patients with lung cancer depend on the tumor histology and the extent of local-regional tumor 
invasion, as well as the location, size, and number of distant metastases. Most patients manifest asymptomatic lesions 
discovered accidentally by chest radiograph or by computed tomography scan. The tumors that appear in the bronchi 
cause resistant cough, heavy breathing or hemoptysis. Tumors that occupy the chest walls usually produce severe 
radicular pain or burning pain, with or without pleural effusion. More than 80% of people visiting a doctor, complain of 
fatigue and reduced activity, and most patients also suffer from cough, dyspnea, anorexia and weight loss. Many 
symptoms in these patients require urgent treatment of the underlying malignancy, as well as palliation of symptoms 
while definitive therapy is given. 
Depending on the histologic type and the stage of the disease, the therapeutic approach may be surgical, radiological, 
and chemotherapeutic. Most often these methods are combined. Surgery is the primary treatment for undiagnosed non-
small cell carcinoma (to 25% of the cases): resection of the pulmonary lobe or entire lung wing. In case of loco-regional 
dissemination (25%) the patient is indicated with a treatment that combines all forms of therapy. In disseminated 
disease (50%) first-line chemotherapy is indicated as a combination of two cytostatics, and if the disease progresses 
further, a second line of chemotherapy is given. Primary treatment for small cell carcinoma, confined to the thoracic 
region, is chemotherapy. Only in a small number of patients can surgical therapy be combined with other therapy. 
Patients with disseminated disease are treated only with chemotherapy. Prophylactic brain radiotherapy is 
administered to patients who have achieved an almost complete response to primary therapy and Symptomatic therapy 
for patients with bronchial cancer. [1-6].  
2. Material and methods 
The global increase in the incidence of lung cancer and the risk of mortality has defined the aim of this study. To obtain 
the results, were analyzed a large number of registered cases of lung cancer and the number of deaths of patients with 
lung cancer. 
The working methods used are: 
 Data from the Strumica Public Health Center for the period 2013-2017. 
 Data from the Institute of Public Health of the Republic of Macedonia for the period 2013-2016. 
The results are processed in detail, analyzed and statistically presented in the paper in tables, graphs, and imagese.  
3. Results and discussion 
Table 1 Number of patients diagnosed with lung cancer in Strumica in 2013, 2014, 2015, 2016 and 2017  
Year Total number of patients 
2013  53 
2014 57 
2015 67 
2016 44 
2017 44 
 
In Strumica for a period of five years a total of 265 people were diagnosed with lung cancer. At the Center for Public 
Health in Strumica in 2013 were diagnosed 53 patients, in 2014 - 57 patients, in 2015 - 67 patients, in 2016- 44 patients 
and in 2017 - 44 patients. In 2014 and 2015 the number of diagnosed patients is increased, while in 2016 and 2017 the 
number decreased. Of the total number, 20% were diagnosed in 2013, 21% were diagnosed in 2014, 25% were 
diagnosed in 2015, in 2016 were diagnosed 17%, and in 2017 17% were diagnosed with lung cancer. 
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Figure 1 Percentage look of the number of people diagnosed with lung cancer per year in Strumica in 2013, 2014, 
2015, 2016 and 2017 year. 
 
Table 2 Number of diagnosed people with lung cancer by gender in Strumica in 2013, 2014, 2015, 2016 and 2017 year 
Year Gender 
 Male                                        Female 
2013 41                                                 12 
2014 47                                                 10 
2015 54                                                 13 
2016 38                                                 06 
2017 33                                                 11 
 
 
Figure 2 Presentation of the number of diagnosed with lung cancer by sex in Strumica in 2013, 2014, 2015, 2016 and 
2017 year 
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According to the data obtained, from the ratio of males to females diagnosed with lung cancer, we can notice that the 
prevalence of lung cancer during the five years is higher in males. The number of males affected is significantly higher, 
totaling 213 ie 80%, in contrast to the total number of female patients that is 52 ie 20%. 
 
Figure 3 Percentage look of lung cancer by sex in period of five years in Strumica 
Table 3 Number of diagnosed women with lung cancer by age in Strumica in period of five years 
Age Number of women diagnosed with lung cancer 
25-31 1 
32-38 1 
39-45 1 
46-52 5 
53-59 13 
60-66 13 
67-73 11 
74-80 3 
81-82 4 
 
Table 4 Number of diagnosed men with lung cancer by age in Strumica in period of five years. 
Age Number of men diagnosed with lung cancer 
24-30 2 
31-37 1 
38-44 4 
45-51 5 
52-58 49 
59-65 61 
66-72 53 
73-79 21 
80-86 11 
87-89 6 
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From the above shown we can conclude that most diagnosed with lung cancer are patients aged 53-59 and 60-66, 
concretely 13 patients or 25%. The youngest diagnosed patient is 25 years old, while the oldest patient is 82 years old. 
In table no. 4 is shown the number of men diagnosed by age, with lung cancer in Strumica for five years, data taken from 
the Strumica Center for Public Health. From the above we can conclude that most diagnosed men with lung cancer are 
on age of 59-65, precisely 61 patients or 29%.The youngest patient is 24 years old, while the oldest patient is 89 years 
old. 
 
Figure 4 Lung cancer mortality in the Republic of Macedonia in the period 2013-2016, the rate of 100 000 
inhabitants. 
Chart 4 shows the mortality rate of lung cancer in the Republic of North Macedonia for a period of four years, ie in the 
period from 2013 to 2016. Data are taken from the Institute of Public Health of the Republic of North Macedonia in 
Skopje. According to the data shown, the highest mortality rate from lung cancer was in 2016, ie 43.7%, then in 2014 
with 42.5%, in 2013 with 40%, and the lowest mortality rate in 2015 with 40.6%. 
4. Conclusion 
Lung cancer is one of the most common and deadly malignancies worldwide. Global increase in lung cancer incidence 
combined with the fact that the overall five-year survival of patients with this disease is less than 15%, highlights the 
magnitude of the lung cancer epidemic. The incidence of lung cancer in the Republic of North Macedonia is relatively 
high, and with more frequent representation of men. Also a huge problem in the country is the late diagnosis of lung 
cancer and the aggravated treatment. It is therefore necessary to recognize the severity of the disease and to treat it 
appropriately.  
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